Paul A. Lakkis


Paul A. Lakkis focuses his practice on corporate and securities matters, primarily representing US and foreign issuers and investment banks in public and private corporate finance transactions. His experience includes working on initial public offerings, follow-on offerings, at-the-market offerings, special purpose acquisition company (SPAC)–related transactions, and mergers and acquisitions. Paul has advised companies in the healthcare, life science, biotechnology, and manufacturing industries. Paul also counsels public companies in connection with annual and quarterly reports, proxy statements, and compliance under US federal securities laws.